JSW
INSM icon

Journey Strategic Wealth’s Insmed INSM Stock Holding History

Journey Strategic Wealth’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$234K Buy
1,433
+262
+22% +$40.3K 0.01% 691
2025
Q4 		$204K Sell
1,171
-317
-21% -$57.8K 0.01% 711
2025
Q3 		$214K Buy
+1,488
New +$182K 0.01% 633
2025
Q2 		– Sell
-2,647
Closed -$202K – 680
2025
Q1 		$202K Buy
+2,647
New +$202K 0.01% 470

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Journey Strategic Wealth's INSM Position: Q1 2026 in Review

Journey Strategic Wealth increased its Insmed (INSM) stake by 22% in Q1 2026, buying an estimated $40.3K and bringing the position to 1,433 shares worth $234K. The position accounts for 0.01% of the portfolio, ranked #691.

Journey Strategic Wealth first reported a position in INSM in Q1 2025 and has held it in 4 quarters since. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Journey Strategic Wealth held 1,433 shares of Insmed worth $234K as of Q1 2026.
  • Journey Strategic Wealth bought 262 Insmed shares in Q1 2026, an estimated $40.3K.
  • Insmed made up 0.01% of Journey Strategic Wealth's portfolio in Q1 2026, its #691 holding.
  • Journey Strategic Wealth first reported a position in Insmed in Q1 2025 and has held it in 4 quarters since.
  • 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.